NCT04352504

Brief Summary

The anti-oxidative and anti-inflammatory effects of polyphenolic compounds of almonds have been reported in limited animal studies and may have the potential to improve skin radiance. However, the skin related beneficial properties of almonds have not been investigated in humans. This study will examine the effects of almond consumption on human skin radiance in Asian women as a pilot.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 25, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 23, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 23, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 9, 2020

Completed
11 days until next milestone

First Posted

Study publicly available on registry

April 20, 2020

Completed
Last Updated

April 20, 2020

Status Verified

April 1, 2020

Enrollment Period

6 months

First QC Date

April 9, 2020

Last Update Submit

April 16, 2020

Conditions

Keywords

skinagingalmonds

Outcome Measures

Primary Outcomes (1)

  • Skin radiance

    Determine the clinical efficacy of almond consumption on skin radiance. The main criteria will be evaluated by clinical scoring using the coloring, luminosity, brightness, and transparency (C.L.B.T.TM)(18) scale and imperfections scale (dark circles, redness/rosacea, spots, and heterogeneity). The C.L.B.T.TM methodology allows assessing different descriptors of the complexion: coloring, luminosity, brightness, and transparency of facial skin.

    12 weeks

Secondary Outcomes (2)

  • UV radiation sensitivity

    12 weeks

  • Skin aging (elasticity, sebum, and hydration/moisture)

    12 weeks

Study Arms (2)

Almonds

EXPERIMENTAL

Consume 1.5 oz. serving almonds (246 calories) daily for 12 weeks

Other: Almond

Pretzels

ACTIVE COMPARATOR

Consume 2 oz. serving pretzels (216 calories) daily for 12 weeks

Other: Pretzel

Interventions

AlmondOTHER

Consume 1.5 oz. serving almonds (246 calories) daily for 12 weeks

Almonds
PretzelOTHER

Consume 2 oz. serving of pretzels (216 calories) daily for 12 weeks

Pretzels

Eligibility Criteria

Age18 Years - 50 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy Asian females age 18-50 years' old (inclusive)
  • Typically consume low fiber/polyphenol diet (beige diet)
  • In good health with a BMI of 22 to 30 kg/ m2 (inclusive)
  • Non-smokers
  • Fitzpatrick Skin type II-IV
  • Willing to maintain their normal skin care pattern for the duration of the study
  • Willing to maintain their normal diet for the duration of the study but avoid almonds and pretzels.
  • Subjects must read and sign the Institutional Review Board-approved written informed consent prior to the initiation of any study specific procedures or enrollment. A subject will be excluded for any condition that might compromise the ability to give truly informed consent.

You may not qualify if:

  • Eating a high fiber/polyphenol diet or taking any medication or dietary supplement which interfere with the absorption of polyphenols.
  • Women who are pregnant, lactating or trying to become pregnant.
  • Currently taking any skin related prescription medication or supplements for less than 3 months.
  • Currently consuming \>14 alcoholic drinks (1 drink = 12 fl oz beer, 4 fl oz wine or 1.5 fl oz liquor) per week and/or unwilling to limit intake to less than 3 drinks per week during study participation or history of alcohol dependency.
  • Screening laboratory value outside of the laboratory normal range that is considered clinically significant for study participation by the investigator.
  • History or current diagnosis of serious medical condition such as Type I or Type II diabetes, major surgery, thyroid disease, heart problems (e.g. angina, bypass surgery, myocardial infarction, etc.), presence of implanted cardiac defibrillator or pacemaker, uncontrolled hypertension/high blood pressure, gastrointestinal disorders including chronic malabsorptive conditions, peptic ulcer disease, Crohn's disease, chronic diarrhea or active gallbladder disease, inflammatory bowel disease, fatty liver or cancer.
  • Known allergy to almonds.
  • Participation in another clinical trial within 30 days prior to enrollment.
  • Any known clinically significant food allergy or intolerance.
  • Currently taking any prescription medication or supplements for less than 3 months.
  • Is unable or unwilling to comply with the study protocol.
  • Subjects who cannot avoid excessive exposure to either natural or artificial sunlight.
  • Received a nasally-delivered steroid, antibiotics within the past 14 days.
  • Used topical antibiotic or topical steroid on the face,currently taking any prescription medications that increase the risk of photosensitivity or history of taking such medications in the less than 3 months (e.g. alpha-hydroxy acids in cosmetics, antibiotics (ciprofloxacin, doxycycline, levofloxacin, ofloxacin, tetracycline, trimethoprim), antifungals (flucytosine, griseofulvin, voriconazole), antihistamines (cetirizine, diphenhydramine, loratadine, promethazine, cyproheptadine)
  • Subjects with a significant medical history or concurrent condition that the investigator(s) feel is not safe for the study
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UCLA Center for Human Nutrition

Los Angeles, California, 90095, United States

Location

MeSH Terms

Conditions

Cutis Laxa

Condition Hierarchy (Ancestors)

Skin Diseases, GeneticGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesConnective Tissue DiseasesSkin and Connective Tissue DiseasesSkin Diseases

Study Officials

  • Zhaoping Li

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: This study will be a randomized, parallel group comparison of almonds vs. isocaloric pretzels.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of Medicine

Study Record Dates

First Submitted

April 9, 2020

First Posted

April 20, 2020

Study Start

July 25, 2019

Primary Completion

January 23, 2020

Study Completion

January 23, 2020

Last Updated

April 20, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations